Navigation Links
Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
Date:11/27/2007

CDC currently recommends that all children from six months up to age five get vaccinated against the flu every year, as well as all persons, including school-aged children, who want to reduce the risk of becoming ill with the flu or transmitting it to others. This includes: children with certain medical conditions; household contacts (parents, siblings, grandparents, etc.) and out-of-home caregivers of children age zero up to age five; and, children and adults who are household contacts of other high-risk individuals.

School-aged children tend to have higher rates of influenza infection because of their close contact with friends and classmates who frequently spread germs among one another. During particularly bad flu seasons, nearly 30 percent of school-aged children get sick and overall miss about 38 million school days a year. A flu vaccine can help children stay free of influenza during the flu season, and potentially help stop the spread of the virus to their families, friends, teachers and communities.

About Families Fighting Flu, Inc.

Families Fighting Flu, Inc. (FFF) is a non-profit, volunteer-based corporation established in 2004 that is made up of families and healthcare practitioners who have experienced first-hand the death of a child due to the flu, or have had a child experience severe medical complications from the flu. FFF is dedicated to educating people about the severity of influenza and the importance of vaccinating children against the flu every year. Through education and advocacy, FFF hopes to improve the rates of annual childhood influenza vaccinations and help reduce the number of childhood illnesses and deaths caused by the flu each year.

To learn when or where to get a flu vaccine, contact your health care provider or local health department. For more information about the flu, please visit http://www.familiesfightingflu.org, or

SOURCE Families Fighting Flu, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , BILLERICA, Mass., Dec. 4 /PRNewswire-...wned subsidiary of Volcano Corporation (Nasdaq: V... successful testing of a novel integrated light so... this proprietary optical engine design raises the...mitations of laser-based designs for swept source ...
(Date:12/4/2009)... , TARRYTOWN, N.Y., Dec. 4 /PRNewswire/ ...rand prize winners of Bayer,s "Express Your Simple... Brothers, selected the winning video entries subm...untry. The grand prize is an in-person meeting tod... diabetes like Nick, are: Caleb, age 6, from Danbu...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Fir...ced that the US Food and Drug Administration (FDA)...pine fumarate) Extended Release Tablets as adjunct...s with Major Depressive Disorder (MDD). SEROQUEL X...the FDA to treat both major depressive disorder as...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results 13409 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 2Micromet Inc Reports Second Quarter 2009 Financial Results 53819 3Micromet Inc Reports Second Quarter 2009 Financial Results 53819 4Micromet Inc Reports Second Quarter 2009 Financial Results 53819 5Micromet Inc Reports Second Quarter 2009 Financial Results 53819 6Micromet Inc Reports Second Quarter 2009 Financial Results 53819 7Micromet Inc Reports Second Quarter 2009 Financial Results 53819 8Micromet Inc Reports Second Quarter 2009 Financial Results 53819 9Micromet Inc Reports Second Quarter 2009 Financial Results 53819 10Micromet Inc Reports Second Quarter 2009 Financial Results 53819 11Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 1Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 2Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 3Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 5Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 6Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 7
...ntisense Drug Targeting Glucagon Receptor for Trea..., CARLSBAD, Calif., Oct. 2 Isis,Pharmaceuticals,...ed $5,million from Ortho-McNeil, Inc. (OMI), a Joh...velopment milestone of initializing the Phase 1,cl...tween Isis and OMI, announced on September 13,2007...
...ority Studies versus Hepsera(R) in Patients with C...Studies will also Assess Clevudine,s Sustained Vir... HBV-, PRINCETON, N.J., Oct. 1 Pharmasset...ase 3 registration clinical trials,of clevudine fo...,infection. Clevudine is an oral, once-daily pyrim...
Other Medicine Technology:Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 2Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 3Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 2Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 3Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 4Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 5
(Date:12/4/2009)...wcasing Innovative Health Product in Scottsdale ,...-- A valley inventor garnering national attention ...weight, prevent disease, restore health, improve m...product at Saturday’s Technology Fair locate... has been featured on major television networks ac...
(Date:12/4/2009)...ewswire/ -- As Congress prepares to vote on a heal...C) today announced an eight week campaign to call ...ousehold on provisions of the Senate health care b...igher taxes, and government-run health care, or th...opposition to the so-called health care reform wil...
(Date:12/4/2009)...ewswire/ -- Farmers Insurance Missouri State Execu...ndy Cole, and Brad Ballard, the CEO and creator of...mers called FireFacts , will conduct a childr...ber 9. ,, (Logo: http://www.newscom.com/cgi...ire safety comes following a tragic fire that took...
(Date:12/4/2009)...al of Neurosurgery: Pediatrics finds that operati...ma, or JPA, tumors in the thalamus of the brain ca...TI. The sensitivity of DTI imaging allows for the.... This information can maximize the potential of ...e to the fiber bundles that are directly related t...
(Date:12/4/2009)...ng manufacturer of over-the-counter topical cream ...rs’ quality of life, today announced that it...edical Association (APMA) Seal of Approval for its... (PRWEB) December 4, 2009 ...e-counter topical cream and first aid products des...
Breaking Medicine News(10 mins):Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2Health News:Missouri Safety Day at the Capitol 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4
...tic manipulation poses, study finds , , TH...ve converted adult cells into embryonic-like stem ...etic manipulation. , Gene manipulation is an older...ally altering them could lead to the development o...
...nerve damage while performing a robotic assisted l...om becoming impotent, according to a study perform...A. , Preoperative MR was used to evaluate 38 neu... Timothy McClure, MD, lead author of the study. "1...
...redict, with a high degree of confidence, whether ...oscopy or removed through polypectomy, according t... School of Medicine and Public Health in Madison, ...p is found with CT colonography, a corresponding p...
..., which usually indicates prior exposure to tuberc...t typically includes a frontal and lateral view. T...al radiation dose during screening, is not necessa...taken in 857 patients with positive PPD (tuberculo...
... following 62-cent increase on cigarettes , , MIN...e on cigarettes has a lot of Minnesotans trying to...oking program provided by ClearWay Minnesota(SM), ...h Insurance Program (SCHIP). , , (Logo: http://...
... 10 Seconds to Care: Help and Hope for Busy Clinic...ishing program of the American College of Physicia...and advice about the healing power of compassionat...and other health care professionals, the timing fo...
Other Medicine News:Health News:Scientists Find New Way to Create Stem Cells 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 3Health News:'Only 10 Seconds to Care' by Dr. Wendy S. Harpham helps heal clinician-patient bonds 2
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: